1.Study on the quality standard of Polygoni Avicularis Herba and its standard decoction
Yiqun WANG ; Sihan SHEN ; Lingyu JIA ; Ran XIE ; Fangji GE ; Yu ZHAO ; Yanjun CHEN ; Qinghe ZHAO
International Journal of Traditional Chinese Medicine 2025;47(11):1581-1585
Objective:To establish a quality control method for the standard decoction of Polygoni Avicularis Herba.Methods:Totally 12 batches of decoction pieces from different origins were collected, the standard decoction was prepared and the quality evaluation method was established, the content of index components in the decoction pieces and the standard decoction was determined with HPLC, the index components, solution pH and other parameters were calculated, and the similarity analysis was carried out against the fingerprints.Results:The total content of myricetin in 12 batches of decoction pieces was >0.12%, and the content of myricetin in the standard decoction was >0.03%, which met the standard of the 2020 edition of the Chinese Pharmacopoeia. The pH value was 5.1-5.5, the transfer rate of myricetin components ranged from 50.0%-106.3%, and the fingerprint study showed that there were 7 common peaks. The similarity analysis results indicated that the standard decoction of 12 batches of decoction pieces of Polygoni Avicularis Herba had good consistency.Conclusion:The preparation process is stable and feasible in line with the traditional decoction preparation method, and can be used for the research and quality evaluation of the standard decoction.
2.Clinicopathological and molecular genetic features of confined placental mosaicism
Aichun WANG ; Junling XIE ; Jianjiang ZHU ; Yuemei ZHANG ; Muyu ZHANG ; Hong QI ; Yiqun GU
Chinese Journal of Pathology 2024;53(7):697-701
Objective:To investigate the clinicopathological and genetic features of confined placental mosaicism (CPM) and its effect on fetal intrauterine growth.Methods:Fourteen CPM cases of Haidian Maternal and Children Health Hospital were collected from May 2018 to March 2022. Clinicopathological examination on placental specimens and molecular genetic analysis were performed.Results:The age of the parturient women ranged from 27 to 34 years, with an average age of (30.0±3.54) years. The gestational weeks ranged from 35 +1 to 41 +2 weeks. There were 4 premature births and 10 term births, among which 6 were female and 8 were male fetuses. Nine cases (9/14) had adverse pregnancy outcomes, including 7 cases of fetal growth restriction. The weight of CPM placenta decreased, with 6 cases below the 10th percentile of weight standards and 5 cases between the 10th and 25th percentile. All 14 CPM placental specimens showed morphological changes of perfusion dysfunction to varying degrees, with mainly placental-maternal vascular malperfusion followed by placental-fetal vascular malperfusion. The mosaic chromosomes in different CPM cases varied, with 16-trisomy/monosomy mosaicism being the most common followed by 7-trisomy and 21-trisomy/monosomy mosaicism. The mosaic proportion was unequal in different parts of the same CPM placenta, with the mosaic proportion of umbilical cord, fetal membranes, fetal surface, maternal surface, and edge ranging from 1% to 70%. Conclusions:The mosaic chromosomes in different CPM cases vary, and the mosaic proportion is unequal in different parts of the same CPM placenta. The pathological morphology is mainly manifested as perfusion dysfunction, which can lead to adverse pregnancy outcomes such as fetal growth restriction and preterm birth.
3.Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial.
Qinhua FAN ; Chongming WU ; Yawei DU ; Boyang WANG ; Yanming XIE ; Zeling ZHANG ; Wenquan SU ; Zizhuo WANG ; Changchang XU ; Xueke LI ; Ying DING ; Xinjiang AN ; Jing CHEN ; Yunying XIAO ; Rong YU ; Nan LI ; Juan WANG ; Yiqun TENG ; Hongfen LV ; Nian YANG ; Yuling WEN ; Xiaoli HUANG ; Wei PAN ; Yufeng LIU ; Xueqin XI ; Qianye ZHAO ; Changshan LIU ; Jian XU ; Haitao ZHANG ; Lie ZHUO ; Qiangquan RONG ; Yu XIA ; Qin SHEN ; Shao LI ; Junhong WANG ; Shengxian WU
Acta Pharmaceutica Sinica B 2024;14(12):5186-5200
The comparison between traditional Chinese medicine Jinzhen oral liquid (JZOL) and Western medicine in treating children with acute bronchitis (AB) showed encouraging outcomes. This trial evaluated the efficacy and safety of the JZOL for improving cough and expectoration in children with AB. 480 children were randomly assigned to take JZOL or ambroxol hydrochloride and clenbuterol hydrochloride oral solution for 7 days. The primary outcome was time-to-cough resolution. The median time-to-cough resolution in both groups was 5.0 days and the antitussive onset median time was only 1 day. This randomized controlled trial showed that JZOL was not inferior to cough suppressant and phlegm resolving western medicine in treating cough and sputum and could comprehensively treat respiratory and systemic discomfort symptoms. Combined with clinical trials, the mechanism of JZOL against AB was uncovered by network target analysis, it was found that the pathways in TRP channels like IL-1β/IL1R/TRPV1/TRPA1, NGF/TrkA/TRPV1/TRPA1, and PGE2/EP/PKA/TRPV1/TRPA1 might play important roles. Animal experiments further confirmed that inflammation and the immune regulatory effect of JZOL in the treatment of AB were of vital importance and TRP channels were the key mechanism of action.
4.Infection sites,pathogen distribution and influencing factors of nosocomial infection after craniocerebral surgery
Yan WANG ; Yiqun ZHOU ; Fengzhu XIE ; Fang CHEN ; Wenting SU
Journal of Navy Medicine 2024;45(5):506-510
Objective To investigate the infection sites,pathogen distribution and risk factors of nosocomial infection after craniocerebral surgery.Methods This is a case-control study.Eighty patients with a mean age of(63.2±8.2)years who developed hospital acquired infections after craniocerebral treatment at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine from January 2018 to December 2021 were assigned to infection group.Eighty patients with a mean age of(61.7±7.8)years who underwent craniocerebral surgery during the same period but did not develop hospital acquired infections were allocated to control group.The medical records and laboratory examination data of the patients were reviewed.Infection sites and pathogen characteristics in patients with hospital acquired infections after craniocerebral surgery were analyzed.Univariate and multivariate analyses were used to explore the risk factors for hospital acquired infections after craniocerebral surgery.Results The respiratory system was mainly infected in the 80 patients with hospital acquired infection after craniocerebral surgery(58.75%),followed by urinary system(22.50%).The main pathogenic bacteria in patients with respiratory system,urinary system and nervous system infections were Gram-negative bacteria.Gram-negative and Gram-positive bacteria in patients with blood system infection accounted for 50%,respectively.There was no significant difference in the composition of pathogenic bacteria among patients with infections in different parts of the body(P>0.05).In 51 patients with Gram-negative bacterial infections,the main pathogenic bacteria were Escherichia coli(26.25%)and Acinetobacter baumannii(15.00%).In 29 patients with Gram-positive bacterial infections,the main pathogenic bacteria were Staphylococcus aureus(16.25%)and Enterococcus faecalis(11.25%).Logistic regression model showed that non class Ⅰ incision,external ventricular drainage,cerebrospinal fluid leakage,non-prophylactic use of antibiotics before surgery,and indwelling catheter were independent risk factors for infection related complications in patients undergoing craniocerebral surgery(all P<0.05).Conclusion The respiratory system and urinary system are mainly involved in patients with nosocomial infection after craniocerebral surgery.The main pathogenic bacteria are Gram-negative bacteria.Non class Ⅰ incisions,external ventricular drainage,leakage of cerebrospinal fluid,non-prophylactic use of antibiotics before surgery,and indwelling catheter may increase the risk of postoperative infection.
5. Steroid-resistant Cronkhite-Canada Syndrome Successfully Treated by Immunosuppressive Agent Combined With Endoscopic Polypectomy
Yueping ZHENG ; Lihua WU ; Bifang WU ; Jie LIU ; Ruizhang SU ; Yiqun HU ; Zeyu ZHENG ; Chenfan LI ; Yun XIE ; Man WAN ; Yiqun HU ; Zhaoxu TIAN
Chinese Journal of Gastroenterology 2021;26(2):126-128
6. Analysis of High Risk Factors for Surgery With Ulcerative Colitis
Yueping ZHENG ; Bifang WU ; Jie LIU ; Ruizhang SU ; Zeyu ZHENG ; Yun XIE ; Man WAN ; Yiqun HU ; Zhaoxu TIAN
Chinese Journal of Gastroenterology 2020;25(12):754-758
Ulcerative colitis (UC) is a chronic non-specific intestinal inflammatory disease. Whether surgical treatment should be taken is a difficult and focus decision of clinical practice. Studies have shown that severe complications, combined with severe infection, poor laboratory indices, and ineffective medical treatment are the evaluation elements of UC surgery. This article reviewed the advances in study on high risk factors of surgery with UC.
7. Gastric Ectopic Pancreas Complicated With Abscess Formation: A Case Report
Xiaoning YANG ; Yun XIE ; Man WAN ; Zeyu ZHENG ; Yiqun HU ; Ruizhang SU ; Bifang WU ; Jie LIU ; Yueping ZHENG ; Yiqun HU
Chinese Journal of Gastroenterology 2020;25(9):574-576
8.Path on the management of surgical graded and refined management based on information technology
Wenjun JIANG ; Dong GUO ; Xijiang ZHAO ; Zhiyi XIE ; Zhiqiang WANG ; Yiqun YANG ; Wenxia DONG
Chinese Journal of Hospital Administration 2019;35(7):540-543
The authors attempted to use information technology in hierarchical management on clinician′s surgical authority. By means of a hierarchical surgery catalogue database, clinicians′ surgical authority is subject to by-level IT-based approval, and such authorities as clinician′s surgical medical advice, application for surgery, and approval of special surgeries are regulated. Thanks to multi-dimensional objective data, clinicians′surgical competence is subject to a dynamic evaluation, hierarchical authorization and reauthorization. These measures further standardize the behavior of the surgeons, and rule out unauthorized operations, thus improving fine management of surgeries and ensuring patient safety.
9.Expression and Clinical Significance of IL-17BR in Inflammatory Bowel Disease
Jingling SU ; Chenxi XIE ; Yanyun FAN ; Yiqun HU ; Lin WANG ; Jianlin REN
Chinese Journal of Gastroenterology 2018;23(2):83-87
Background:There is no specific therapy for inflammatory bowel disease(IBD),and the pathogenesis of IBD is not fully clear. Aims:To explore the expression and clinical significance of IL-17BR in colon mucosa and peripheral blood mononuclear cell(PBMC)of patients with IBD. Methods:Colon mucosal biopsy specimens of 40 Crohn's disease(CD) patients,32 ulcerative colitis(UC)patients and 25 healthy controls and PBMC of 30 CD patients,27 UC patients and 25 healthy controls were collected. The expressions of IL-17BR in colon mucosa and PBMC were determined by immunohistochemistry and flow cytometry,respectively,and correlations between IL-17BR expression and levels of CRP, ESR,CDAI score and Mayo score were analyzed. Serum levels of TNF-α before and after infliximab(IFX)treatment were determined by ELISA,and correlations with IL-17BR were analyzed. Results:Compared with healthy controls,IL-17BR expressions in colon mucosa of CD and UC patients were significantly increased(P<0.05). IL-17BR expressions were significantly higher in active CD and UC patients than in remission CD and UC patients(P <0.05). No significant differences in IL-17BR expression in PBMC were found among CD,UC patients and healthy controls(P>0.05). The expression of IL-17BR in colon mucosa was positively correlated with CRP,ESR,CDAI score or Mayo score in CD,UC patients(P <0.05). After treatment with IFX,expression of IL-17BR in colon mucosa and serum TNF-α level were significantly decreased in CD patients(P<0.01). Expression of IL-17BR was positively correlated with serum TNF-α level in CD patients(P<0.05). Conclusions:The increasing of IL-17BR expression in IBD patients is closely correlated with activity of inflammation and TNF-α level. IL-17BR may play a vital role in immune response of intestinal mucosa,and can be used as a new marker for reflecting the activity of IBD.
10.Association of nocturnal serum cortisol level with diabetic microvascular complications in overweight/obese type 2 diabetic patients
Aobo FU ; Yuting XIE ; Binbin HE ; Lin YANG ; Shuoming LUO ; Jingjing ZHANG ; Yang XIAO ; Zhen WANG ; Wei LIU ; Qiong FENG ; Chen CHAO ; Yalin YANG ; Zhifeng SHENG ; Xin SU ; Yiqun PENG ; Xia LI ; Zhiguang ZHOU
Chinese Journal of Endocrinology and Metabolism 2018;34(10):834-838
Objective To explore the association of nocturnal serum cortisol levels with diabetic microvascular complications in overweight or obese patients with type 2 diabetes mellitus. Methods Serum cortisol levels of 316 overweight or obese type 2 diabetic patients were tested at midnight by the method of chemiluminescence. Diabetic microvascular complications were compared among various groups according to nocturnal serum cortisol levels. All the patients with nocturnal serum cortisol level > 50 nmol/L were asked to undergo overnight low-dose dexamethasone suppression test to rule out the possibility of subclincal Cushing's syndrome. The incidences of diabetic nephropathy ( DN ) , diabetic retinopathy ( DR ) , and diabetic peripheral neuropathy ( DPN ) were examined in all the patients. Results (1)The incidence of DN was gradually increased from 13.3%to 27.7%and 44.2%in patients with low, medium, and high cortisol level groups, showing a statistical difference among 3 groups ( P<0.05) . The incidences of DR in medium and high cortisol level groups were higher than that in low cortisol level group (40.6%and 47.7%vs 22.7%, both P<0.01). The incidence of DPN in high cortisol level group was higher as compared with low cortisol level group (60.5% vs 38.7%, P<0.01). (2) Nocturnal serum cortisol level in patients with diabetic microvascular complications was higher than that in patients without complications [ (136.87 ± 105.78 vs 97.55 ± 93.48) nmol/L, P<0.01]. Nocturnal serum cortisol level in patients with multiple diabetic microvascular complications was higher than that in patients with single diabetic microvascular complication [ (151.66±114.54vs117.69±90.26)nmol/L,P<0.05].(3)Singlefactorlogisticregressionanalysisshowedthat higher nocturnal serum cortisol level was a risk factor for diabetic microvascular complications in addition to female, age, longer diabetic duration, higher fasting plasma glucose ( FPG ) . Multivariate logistic regression analysis showed that higher nocturnal serum cortisol level was still a risk factor for diabetic microvascular complications after adjusted by diabetic duration, FPG, HbA1C, and the use of insulin (P=0.013). Conclusion Nocturnal serum cortisol level seems to be a risk factor for diabetic microvascular complications in overweight or obese patients with type 2 diabetes mellitus.

Result Analysis
Print
Save
E-mail